Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» clinical trials
clinical trials
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes
Yahoo Finance
Mon, 08/22/22 - 10:00 am
Novo Nordisk
clinical trials
CagriSema
semaglutide
diabetes
type 2 diabetes
Maplight concludes Phase I trial of schizophrenia and dyskinesia therapy
Clinical Trials Arena
Fri, 08/19/22 - 10:38 am
Maplight Therapeutics
clinical trials
ML-007
schizophrenia
dyskinesia
CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial
Clinical Trials Arena
Fri, 08/19/22 - 10:31 am
CureVac
clinical trials
MRNA
CV0501
boosters
COVID-19
Pfizer discontinues development of dilated cardiomyopathy drug emprumapimod
Clinical Trials Arena
Thu, 08/18/22 - 11:14 pm
Pfizer
dilated cardiomyopathy
clinical trials
emprumapimod
Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial
BioSpace
Thu, 08/18/22 - 12:45 pm
Jazz Pharma
Epidiolex
clinical trials
pediatrics
epilepsy
cannabindoids
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Fierce Biotech
Thu, 08/18/22 - 12:40 pm
Astellas
menopause
FDA
clinical trials
Asia
fezolinetant
hot flashes
CSL reports Phase III data for garadacimab to treat hereditary angioedema
Clinical Trials Arena
Thu, 08/18/22 - 12:30 pm
CSL
clinical trials
garadacimab
HAE
hereditary angiodema
FDA lifts partial hold on Curis' lymphoma study — shares spike
Endpoints
Thu, 08/18/22 - 11:08 am
FDA
Curis
lymphoma
clinical trials
emavusertib
Blueprint drug succeeds in rare disease study important to its market prospects
BioPharma Dive
Wed, 08/17/22 - 10:55 am
Blueprint Medicines
systemic mastocytosis
clinical trials
Ayvakit
Sanofi scraps oral SERD strategy after 2nd failure in breast cancer
Fierce Biotech
Wed, 08/17/22 - 10:50 am
Sanofi
SERD
breast cancer
clinical trials
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
Endpoints
Tue, 08/16/22 - 11:59 pm
AbbVie
CD47
SEC
clinical trials
I-Mab
Zai Lab
Ventyx touts early data for potential rival to Bristol Myers psoriasis drug
BioPharma Dive
Tue, 08/16/22 - 12:22 pm
Ventyx Biosciences
clinical trials
Bristol Myers Squibb
psoriasis
VTX958
deucravacitinib
Genprex to progress Phase I/II trial of non-small cell lung cancer therapy
Clinical Trials Arena
Tue, 08/16/22 - 12:15 pm
Genprex
clinical trials
Reqorsa
AstraZeneca
Tagrisso
non-small cell lung cancer
Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial
Clinical Trials Arena
Tue, 08/16/22 - 11:12 am
Anixa Biosciences
clinical trials
CAR-T
ovarian cancer
Clene claims its PhII MS trial, half its intended size, cleared the primary goal. But can the biotech afford PhIII?
Endpoints
Mon, 08/15/22 - 10:23 am
Clene Nanomedicine
multiple sclerosis
MS
clinical trials
BrainStorm’s ALS Drug Heads to the FDA with Correction to Phase III Analyses
BioSpace
Mon, 08/15/22 - 10:17 am
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
clinical trials
Novartis bid to repurpose rare disease drug for cancer falls short in third trial
BioPharma Dive
Mon, 08/15/22 - 10:15 am
Novartis
cancer
clinical trials
lung cancer
canakinumab
Walls close in on VistaGen's PALISADE anxiety trial program in wake of phase 3 failure
Fierce Biotech
Sun, 08/14/22 - 10:37 pm
VistaGen
anxiety
clinical trials
social anxiety
Odyssey reports positive data from Phase I concussion trial
Clinical Trials Arena
Fri, 08/12/22 - 10:25 am
Odyssey Health
clinical trials
PRV-002
concussions
Larimar to respond to FDA this quarter on 15-month clinical hold of PhI Friedreich's ataxia drug
Endpoints
Fri, 08/12/22 - 10:23 am
Larimar Therapeutics
CTI-1601
clinical trials
FDA
Friedreich's Ataxia
Pages
« first
‹ previous
…
52
53
54
55
56
57
58
59
60
…
next ›
last »